case_images: PMC8425345_01
case_images: (A) Chest computer tomography (CT) showing SARS-COV2 pneumonia with bilateral patchy ground-glass opacities. (B) After four months from the diagnosis, the Chest CT of the same patient shows almost complete resolution of radiological findings.
case_images: mjhid-13-1-e2021057f1.jpg
case_images: PMC8425345_01_mjhid-13-1-e2021057f1.jpg
case_images: f1-mjhid-13-1-e2021057
case_images: Chest CT evidenced bilateral patchy ground-glass opacities, consistent with COVID-19 pneumonia (Figure 1-A). A new chest CT scan repeated four months later showed extensive resolution of lung infiltrates (Figure 1-B). An unrelated donor was identified, but the patient refused to undergo allogeneic transplantation.
case_images: Full blood count parameters are shown; white blood cell count (WBC, reference range 0.49-5.51 xx109/L), neutrophils (0.02-3.88 x 109/L) and platelets (54-487 x 109/L). Venetoclax + Azacitidine administration, starting from day 20 onwards, is indicated by the blue bar.
case_images: mjhid-13-1-e2021057f2.jpg
case_images: PMC8425345_01_mjhid-13-1-e2021057f2.jpg
case_images: f2-mjhid-13-1-e2021057
case_images: Blood tests showed severe neutropenia (neutrophils 0.55 x 109/L), mild thrombocytopenia (platelets 115 x 109/L), and anemia (Hb 50 g/L) (Figure 2). Complete recovery of blood counts was observed 46 days after treatment initiation (Figure 2), and antibiotic and antifungal therapy was suspended.